Synnovation Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Synnovation Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer (NCT07756281) | Synnovation Therapeutics, Inc. | 2026-09-01 |
| SNV1521 in Participants With Advanced Solid Tumors (NCT06220864) | Synnovation Therapeutics, Inc. | 2024-02-23 |
Track Synnovation Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.